Delivery Order SPE2DB20D2104-SPE2DB25FMWMD
- Not listed
- The Defense Logistics Agency awarded a $8,547.90 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on June 18, 2025, with an ultimate completion date of July 11, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor at its Conshohocken, Pennsylvania location. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.72 to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX on July 10, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Botox 100 unit vials with a ceiling value of $2,584.08. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,564.37 to supply Botox 200 unit vials, with an ultimate completion date of August 20, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,306.80 to AmerisourceBergen Drug Corp for the supply of Botox 100 Unit Vials. This firm fixed price, competitively awarded contract was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $20,672.64 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of 100-unit vials of Botox, with an ultimate completion date of June 24, 2025. This non-set-aside competitive award is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Botox 100 unit vials valued at $10,336.32. This firm fixed-price delivery order, with a completion date of August 11, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating open competition. This delivery order is a child contract issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,460.20 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 Unit Vials, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger relationship with DLA. The pharmaceutical products will be delivered to the company's location in Conshohocken, Pennsylvania, supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BOTOX 100 Unit Vials valued at $4,306.80 on August 5, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWMDDelivery Order
The Defense Logistics Agency awarded a $2,564.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award was issued on July 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's existing relationship with DLA for pharmaceutical supply. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and other government healthcare systems worldwide. The company's established track record with DLA, demonstrated through numerous competitively awarded contracts with firm fixed pricing across multiple therapeutic domains, positions it as a key supplier for federal medical procurement needs, including specialized products such as BOTOX for military medical applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/25/25 |